- Home
- Publications
- Publication Search
- Publication Details
Title
MuvB: A Key to Cell Cycle Control in Ovarian Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-06-11
DOI
10.3389/fonc.2018.00223
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High MYBL2 expression and transcription regulatory activity is associated with poor overall survival in patients with hepatocellular carcinoma
- (2018) Z. Guan et al. Current Research in Translational Medicine
- A wake-up call to quiescent cancer cells - potential use of DYRK1B inhibitors in cancer therapy
- (2017) Walter Becker FEBS Journal
- Central spindle proteins and mitotic kinesins are direct transcriptional targets of MuvB, B-MYB and FOXM1 in breast cancer cell lines and are potential targets for therapy
- (2017) Patrick Wolter et al. Oncotarget
- The DREAM complex through its subunit Lin37 cooperates with Rb to initiate quiescence
- (2017) Christina FS Mages et al. eLife
- Human papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway
- (2017) Martin Fischer et al. Scientific Reports
- A chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibition
- (2016) Hyeongki Kim et al. Disease Models & Mechanisms
- Primary and acquired platinum-resistance among women with high grade serous ovarian cancer
- (2016) Katrina Slaughter et al. GYNECOLOGIC ONCOLOGY
- A Systematic Analysis of Negative Growth Control Implicates the DREAM Complex in Cancer Cell Dormancy
- (2016) James MacDonald et al. MOLECULAR CANCER RESEARCH
- Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks
- (2016) Martin Fischer et al. NUCLEIC ACIDS RESEARCH
- An important role for Myb-MuvB and its target gene KIF23 in a mouse model of lung adenocarcinoma
- (2016) F Iltzsche et al. ONCOGENE
- Structural basis for LIN54 recognition of CHR elements in cell cycle-regulated promoters
- (2016) Aimee H. Marceau et al. Nature Communications
- Timing of transcription during the cell cycle: Protein complexes binding to E2F, E2F/CLE, CDE/CHR, or CHR promoter elements define early and late cell cycle gene expression
- (2016) Gerd A. Müller et al. Oncotarget
- DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome
- (2016) Arnaud Duchon et al. Frontiers in Behavioral Neuroscience
- Proteomic Landscape of Tissue-Specific Cyclin E Functions in Vivo
- (2016) Junko Odajima et al. PLoS Genetics
- Structural mechanisms of DREAM complex assembly and regulation
- (2015) Keelan Z. Guiley et al. GENES & DEVELOPMENT
- Deregulation of the FOXM1 target gene network and its coregulatory partners in oesophageal adenocarcinoma
- (2015) Elizabeth F Wiseman et al. Molecular Cancer
- The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes
- (2015) Martin Fischer et al. NUCLEIC ACIDS RESEARCH
- DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications
- (2015) Ramzi Abbassi et al. PHARMACOLOGY & THERAPEUTICS
- Survivin – The inconvenient IAP
- (2015) Dario C. Altieri SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex
- (2015) Martin Fischer et al. Oncotarget
- The DREAM complex in antitumor activity of imatinib mesylate in gastrointestinal stromal tumors
- (2014) James A. DeCaprio et al. CURRENT OPINION IN ONCOLOGY
- Loss of the Mammalian DREAM Complex Deregulates Chondrocyte Proliferation
- (2014) C. Forristal et al. MOLECULAR AND CELLULAR BIOLOGY
- The CHR site: definition and genome-wide identification of a cell cycle transcriptional element
- (2014) Gerd A. Müller et al. NUCLEIC ACIDS RESEARCH
- A novel DYRK1B inhibitor AZ191 demonstrates that DYRK1B acts independently of GSK3β to phosphorylate cyclin D1 at Thr286, not Thr288
- (2013) Anne L. Ashford et al. BIOCHEMICAL JOURNAL
- The DREAM Complex Mediates GIST Cell Quiescence and Is a Novel Therapeutic Target to Enhance Imatinib-Induced Apoptosis
- (2013) S. Boichuk et al. CANCER RESEARCH
- An international assessment of ovarian cancer incidence and mortality
- (2013) Kimberly A. Lowe et al. GYNECOLOGIC ONCOLOGY
- Mirk/dyrk1B Kinase in Ovarian Cancer
- (2013) Eileen Friedman INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Human papillomavirus type 16 E7 perturbs DREAM to promote cellular proliferation and mitotic gene expression
- (2013) J A DeCaprio ONCOGENE
- p53 and Cell Cycle Dependent Transcription of kinesin family member 23 (KIF23) Is Controlled Via a CHR Promoter Element Bound by DREAM and MMB Complexes
- (2013) Martin Fischer et al. PLoS One
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- LIN54 harboring a mutation in CHC domain is localized to the cytoplasm and inhibits cell cycle progression
- (2012) Taira Matsuo et al. CELL CYCLE
- p53 can repress transcription of cell cycle genes through a p21WAF1/CIP1-dependent switch from MMB to DREAM protein complex binding at CHR promoter elements
- (2012) Marianne Quaas et al. CELL CYCLE
- The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression
- (2012) S. Sadasivam et al. GENES & DEVELOPMENT
- Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition
- (2012) Jing Hu et al. INTERNATIONAL JOURNAL OF CANCER
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly
- (2011) L. Litovchick et al. GENES & DEVELOPMENT
- Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53
- (2011) Diego F. Calvisi et al. HEPATOLOGY
- Disruption of repressive p130-DREAM complexes by human papillomavirus 16 E6/E7 oncoproteins is required for cell-cycle progression in cervical cancer cells
- (2011) N. Nor Rashid et al. JOURNAL OF GENERAL VIROLOGY
- Inactivation of Mirk/Dyrk1b Kinase Targets Quiescent Pancreatic Cancer Cells
- (2011) D. Z. Ewton et al. MOLECULAR CANCER THERAPEUTICS
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- The CHR promoter element controls cell cycle-dependent gene transcription and binds the DREAM and MMB complexes
- (2011) Gerd A. Müller et al. NUCLEIC ACIDS RESEARCH
- Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)
- (2010) Tatyana Adayev et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Lin9, a Subunit of the Mammalian DREAM Complex, Is Essential for Embryonic Development, for Survival of Adult Mice, and for Tumor Suppression
- (2010) N. Reichert et al. MOLECULAR AND CELLULAR BIOLOGY
- Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity
- (2010) Frédéric Chibon et al. NATURE MEDICINE
- Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A
- (2010) Yasushi Ogawa et al. Nature Communications
- The Kinase Mirk/dyrk1B: A Possible Therapeutic Target in Pancreatic Cancer
- (2010) Eileen Friedman Cancers
- B-MYB Is Required for Recovery from the DNA Damage-Induced G2 Checkpoint in p53 Mutant Cells
- (2009) M. Mannefeld et al. CANCER RESEARCH
- LIN54 is an essential core subunit of the DREAM/LINC complex that binds to the cdc2 promoter in a sequence-specific manner
- (2009) Fabienne Schmit et al. FEBS Journal
- How the Rb tumor suppressor structure and function was revealed by the study of Adenovirus and SV40
- (2009) James A. DeCaprio VIROLOGY
- In vitro and in vivo analysis of B-Myb in basal-like breast cancer
- (2008) A R Thorner et al. ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started